The federal government has launched a new program called Medicare GLP-1 Bridge, making expensive GLP-1 weight loss drugs more affordable for many older Americans. Starting Wednesday, certain Medicare and Medicare Advantage beneficiaries can access these medications for $50 a month until the end of 2027. This initiative is the first time insurance covers GLP-1s, which are glucagon-like peptide-1 receptor agonists, for weight loss in older adults. However, eligibility is based on specific health criteria, such as a body mass index (BMI) of 35 or higher, or a BMI of 27 with another health condition. The program aims to gather data for potential long-term coverage while providing immediate financial relief. Only certain GLP-1 drugs are included, and those already covered for conditions like diabetes are not eligible. Interested individuals should consult their healthcare providers to see if they qualify.
QUESTION: How might the availability of affordable weight loss medications impact the health and lifestyle choices of older adults?
Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know
